免疫分析市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

免疫测定市场按类型(放射免疫测定、酶免疫测定、荧光免疫测定、化学发光免疫测定、其他)、应用、最终用户和地理细分

市场快照

Immunoassays Market
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 7.8 %
 Immunoassays Market Research

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

导致免疫测定市场增长的因素包括成本效益、生物技术和制药领域的增长以及免疫测定的高灵敏度和特异性。

与传统测试相比,免疫测定已被证明即使对于非常小的样本也能提供高度准确的结果。这些免疫测定被认为具有 1pg/ml 的检测限,这可归因于免疫测定完全基于免疫反应这一事实。免疫反应是高度特异性的,因为它们只能在适当的免疫试剂存在的情况下发生。例如,针对病毒蛋白的抗体不能与源自细菌的抗原结合。这种高特异性表明结果的高精度,这使得检测疾病具有高灵敏度。这种高灵敏度不仅有助于轻松检测,而且无需二次验证,最终节省了大量成本。因此,高灵敏度、特异度、免疫测定的成本节约性质正在推动免疫测定市场的增长。然而,复杂的检测程序和与免疫检测相关的限制等因素可能会阻碍市场增长。

报告范围

免疫测定是一种依靠生物化学来测量分析物的存在和浓度的测试。分析物可以是大蛋白质、人因感染而产生的抗体或小分子。免疫测定具有高度敏感性和特异性。它们的高特异性源于使用抗体和纯化抗原作为试剂。

By Type
Radioimmunoassay (RIA)
Enzyme Immunoassays (EIA)
Fluoroimmnoassay (FIA)
Chemiluminescenceimmunoassay(CLIA)
Others
By Application
Disease Diagnosis
Therapeutic Drug Monitoring
Drug Discovery
Clinical Chemistry
Hematology
Others
By End User
Hospitals
Pharma & Biotech Companies
Clinical Laboratories
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

酶免疫测定 (EIA) 细分市场有望在全球免疫测定市场中占有重要的市场份额

  • 在酶免疫测定法 (EIA) 中,免疫试剂附着在酶上。在免疫反应后,酶从免疫剂中释放出来。然后它与基材发生反应,导致颜色变化。测定结果与颜色变化的强度成正比。EIA 也称为酶联免疫吸附试验 (ELISA)。
  • EIA 易于执行,几乎不需要专门的设备,经验丰富的实验室技术人员和研究实验室新手都可以快速学习 EIA 技能。但是,更好地了解 EIA 的要素和设计是有用的。
  • 由于工作原理简单,酶免疫测定是所有免疫测定中最具成本效益的。因此,它们在全球免疫分析市场中占有最大份额。
Immunoassays Market Share

北美在市场上占主导地位,预计在预测期内也会如此

目前,北美在免疫分析市场上占主导地位,预计将在未来几年继续占据主导地位。在北美地区,美国占有最大的市场份额。这主要归因于慢性病、传染病发病率的上升、老年人口数量的增加,以及该地区发达的医疗基础设施和医疗器械的普及率不断提高。此外,政府组织和制药公司对慢性病和糖尿病等疾病和疾病的高额研发支出是推动区域市场的一些主要因素。

Immunoassays Market Size

竞争格局

免疫分析市场竞争适度,由几个主要参与者组成。就市场份额而言,目前很少有主要参与者主导市场。随着医疗保健发展需求的增加和免疫分析的进步,预计很少有其他较小的参与者进入市场。该市场的一些主要参与者包括雅培公司、Becton Dickinson and Company、丹纳赫公司、Hologic Inc. 和 Qiagen NV 等。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 High Sensitivity and Specificity of Immunoassays

      2. 4.2.2 Technological Advancements in Immunoassay Instruments

      3. 4.2.3 Increasing Prevalence of Chronic and Infectious Diseases

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulatory Scenario for Approval of Immunoassays

      2. 4.3.2 Complexity of Procedures

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Type

      1. 5.1.1 Radioimmunoassay (RIA)

      2. 5.1.2 Enzyme Immunoassays (EIA)

      3. 5.1.3 Fluoroimmnoassay (FIA)

      4. 5.1.4 Chemiluminescenceimmunoassay(CLIA)

      5. 5.1.5 Others

    2. 5.2 By Application

      1. 5.2.1 Disease Diagnosis

      2. 5.2.2 Therapeutic Drug Monitoring

      3. 5.2.3 Drug Discovery

      4. 5.2.4 Clinical Chemistry

      5. 5.2.5 Hematology

      6. 5.2.6 Others

    3. 5.3 By End User

      1. 5.3.1 Hospitals

      2. 5.3.2 Pharma & Biotech Companies

      3. 5.3.3 Clinical Laboratories

      4. 5.3.4 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle East & Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle East & Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Becton Dickinson and Company

      3. 6.1.3 Danaher Corporation

      4. 6.1.4 Devon Medical Products

      5. 6.1.5 EDP Biotech Corporation

      6. 6.1.6 Hologic Inc.

      7. 6.1.7 Luminex Corporation

      8. 6.1.8 Meridian Life Science Inc.

      9. 6.1.9 Qiagen NV

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Immunoassays Market market is studied from 2018 - 2026.

The Immunoassays Market is growing at a CAGR of 7.8% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Abbott Laboratories Inc., Becton Dickinson and Company, Danaher Corporation, Hologic Inc., Qiagen NV are the major companies operating in Immunoassays Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!